Alnylam Pharmaceuticals: Promising Advancements in Alzheimer’s Treatment with RNA Interference Therapeutics
Analyst Patrick Trucchio of H.C. Wainwright reiterated a Buy rating on Alnylam Pharma (ALNY – Research Report), boosting the price target to ...
bovnews11h
Verrica Pharmaceuticals Inc (VRCA) Stock: Analyzing Its Quiet Power
On Wednesday, Verrica Pharmaceuticals Inc (VRCA) stock saw a modest uptick, ending the day at $1.24 which represents a slight increase of $0.13 or 11.71% from the prior close of $1.11. The stock ...
Business Insider19h
Medigene’s Strategic Realignment: Enhancing R&D Efficiency and Extending Cash Runway
Analyst Joseph Pantginis from H.C. Wainwright maintained a Buy rating on the stock and has a €1.00 price target. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks ...
bovnews6h
Why Did Jefferies Give Lyra Therapeutics Inc (LYRA) Stock Hold Rating?
On Wednesday, Lyra Therapeutics Inc (LYRA) stock saw a decline, ending the day at $0.19 which represents a decrease of $-0.01 or -5.00% from the prior close of $0.2. The stock opened at $0.2 and ...
Crypto's Big Bang: Hut 8 Skyrocket by Over 150% as Trump's Bitcoin Plan Promises a New Era
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
Hosted on MSN16h
Bitcoin Miner Iren Sees Target Hikes On Earnings; Bitcoin Rebounds Above $96k
Bitcoin miner Iren received price target hikes after reporting earnings, 28% spike in AI revenue. Bitcoin price rebounds ...